Finally our company name is on, and our logo is on the walls. ๐ฅ๏ธ ๐ฉบ๐ง
While this marks an exciting new chapter ๐ for us at @NEUROBITSTECH, it also feels especially meaningful for me personally.
Finally our company name is on, and our logo is on the walls. ๐ฅ๏ธ ๐ฉบ ๐ง
While this marks an exciting new chapter ๐ for us at @NEUROBITSTECH , it also feels especially meaningful for me personally.
โก๏ธ The findings led our CEO to develop a test, called MetaboTest with 99% accuracy of detecting the multiple sclerosis using as a treatment decision in multiple sclerosis diagnosis! #whatwedo
๐ง Multiple sclerosis (MS) is one of the most common chronic inflammatory diseases of the central nervous system and follows a relapsing course. ย ๐ง
Excited to share the work from our CEO - Dr. sc. Andrea Komljenovic,ย her ***first-author paper in Nature Journals*** doing bioinformatics analysis/modeling in medicine and that is our work, is now published in Nature Immunology.ย ๐ฐ https://t.co/VjC1S3ko2L
Explore how weโre working to improve the lives of patients with neurological diseases & cancerโwho we serve, what we do, and why it matters.
Many thanks to all collaborators and business partners for the fantastic collaboration!
#neurobitstech#techcompany#software